ArticleJournal of neurosurgery. Case lessons2026
A rare case of intradural extramedullary anaplastic ependymoma: a 35-month survival update following resection and adjuvant proton beam radiation therapy. Illustrative case.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntradural extramedullary anaplastic ependymomas are rare, aggressive spinal tumors for which optimal management strategies remain unclear. OBSERVATIONS: This case describes ongoing survival at 35 months in a 65-year-old male with an intradural extramedullary anaplastic ependymoma treated with subtotal resection and proton beam therapy. MRI revealed a T2-3 dorsal intradural extramedullary lesion with leptomeningeal spread in the lumbar spine. Subtotal resection was performed due to dense adherence to the cord, with approximately 10% tumor left in situ. Pathological evaluation confirmed MYCN-amplified WHO grade 3 ependymoma. Adjuvant proton beam therapy was initiated within 2 weeks of surgery, consisting of craniospinal irradiation (3600 cGy in 20 fractions) followed by a boost to a total of 5400 cGy in 30 fractions. Postoperative recovery included full return of strength and function. Serial brain and spine MRI studies at 6, 12, 18, and 22 months showed stable spinal dissemination with no intracranial spread. LESSONS: This case supports the role of subtotal resection followed by proton beam therapy as a viable treatment strategy for MYCN-amplified intradural extramedullary anaplastic ependymomas, particularly when gross-total resection is contraindicated. https://thejns.org/doi/10.3171/CASE25804.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.